Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
申请人:Flagship Pioneering Innovations V, Inc.
公开号:US10953027B2
公开(公告)日:2021-03-23
Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
Acylated active agents and methods of their use for the treatment of autoimmune disorders
申请人:Flagship Pioneering Innovations V, Inc.
公开号:US11058698B2
公开(公告)日:2021-07-13
Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
本文公开了酰化活性剂及其使用方法,例如用于调节自身免疫标记物或治疗自身免疫性疾病的方法。
WO2019236775A5
申请人:——
公开号:WO2019236775A5
公开(公告)日:2022-06-13
[EN] MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME<br/>[FR] AGENTS MULTIBIOTIQUES ET PROCÉDÉS D'UTILISATION DE CEUX-CI